| Members |
targetComponentId |
| glycerin 30 %, ögondroppar |
Product containing only glycerol in ocular dose form (medicinal product form) |
| glycerin 30 %, ögondroppar utan konserveringsmedel |
Product containing only glycerol in ocular dose form (medicinal product form) |
| glycerin 50 %, ögondroppar |
Glycerol 500 mg/mL eye solution |
| glycerin 50 %, ögondroppar utan konserveringsmedel |
Glycerol 500 mg/mL eye solution |
| glycerin 50 %, lösning |
Glycerol only product |
| glycerol, suppositorium för spädbarn 1 g |
Product containing precisely glycerol 1 gram/1 each conventional release rectal suppository (clinical drug) |
| glycerol, suppositorium för barn 2 g |
Glycerol 2 g rectal suppository |
| glycerol, suppositorium för vuxna 4 g |
Product containing precisely glycerol 4 gram/1 each conventional release rectal suppository (clinical drug) |
| Glycerol kinase deficiency |
Deficiency of glycerol kinase |
| glyceryltrinitrat 0,4 %, salva |
Product containing only glyceryl trinitrate (medicinal product) |
| nitroglycerin 2 mg, buckaltablett med modifierad frisättning |
Glyceryl trinitrate 2 mg buccal tablet |
| nitroglycerin 3 mg, buckaltablett med modifierad frisättning |
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) |
| nitroglycerin 5 mg, buckaltablett med modifierad frisättning |
Glyceryl trinitrate 5 mg buccal tablet |
| nitroglycerinsprejallergi |
Allergy to nitroglycerin |
| Glycosidase |
Glycosidase |
| Glycosyltransferase |
Glycosyltransferase |
| getmjölk |
Goat's milk |
| Gomphocarpus physocarpus |
Asclepias physocarpus (organism) |
| Gomphrena physocarpus |
Asclepias physocarpus (organism) |
| Gorissennes tecken |
Jorissenne sign |
| Goura cristata cristata |
Goura cristata (organism) |
| Gout with other manifestation, NEC |
Gout |
| grad av dysplasi i adenom vid proximal resektionskant |
Histologic grade of dysplasia at proximal surgical margin |
| Grafting of bone, autogenous or bone bank |
Bone graft |
| Grafting of tarsal or metatarsal |
Grafting of phalanges of foot |
| Grahamella |
Bartonella |
| Grahamella peromysci |
Bartonella peromysci |
| Grahamella species |
Bartonella |
| Grahamella talpae |
Bartonella peromysci |
| Grahamellosis |
Bartonellosis |
| Granuloma of lacrimal passages |
Lacrimal sac granuloma |
| granulom i operationssår |
Granuloma of surgical wound (finding) |
| granulovakuolär degeneration av typ Simchowicz |
Granulovacuolar degeneration (morphologic abnormality) |
| Graphosid spider |
Order Araneae (organism) |
| Gray elder pollen |
Grey alder pollen (substance) |
| Great vessel repair with unlisted major procedure |
Repair of great vessels |
| Greenfieldfilter |
Vena cava filter |
| griseofulvin av mikrostorlek, 125 mg/5 ml, suspension |
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Griseofulvin, microsize 125mg/mL suspension |
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Gross stress reaction |
Acute stress disorder |
| Guaiac test |
Chemical test for occult blood |
| guajfenesin 50 mg +oxtrifyllin 100 mg, elixir |
Product containing only guaifenesin and theophylline in oral dose form (medicinal product form) |
| guajfenesin 100 mg + teofyllinnatriumglycinat 300 mg, elixir |
Product containing only guaifenesin and theophylline in oral dose form (medicinal product form) |
| guajfenesin 100 mg/5 ml, sirap |
Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
| guajfenesin 1 200 mg + dextrometorfan 60 mg, depåtablett |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
| guajfenesin 1 200 mg + pseudoefedrin 120 mg, depåtablett |
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 1 200 mg, tablett med modifierad frisättning |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 1 200 mg med modifierad frisättning + dextrometorfan 60 mg, tablett |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
| guajfenesin 1 200 mg med modifierad frisättning + pseudoefedrin 120 mg, tablett |
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 1 200 mg, depåtablett |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 300 mg, kapsel med modifierad frisättning |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 300 mg, depåkapsel |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 50 mg/ml |
Product containing only guaifenesin (medicinal product) |
| guajfenesin 600 mg + dextrometorfan 30 mg, depåtablett |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 600 mg + pseudoefedrin 60 mg, depåtablett |
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 600 mg, kapsel med modifierad frisättning |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 600 mg med modifierad frisättning + dextrometorfan 30 mg, tablett |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 600 mg med modifierad frisättning + pseudoefedrin 60 mg, tablett |
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 600 mg, depåkapsel |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guanetidinmonosulfat 0,25 %, ögondroppar |
Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| guanetidinmonosulfat 0,5 %, ögondroppar |
Guanethidine 5 mg/mL eye solution |
| guanetidinmonosulfat 1 %, ögondroppar |
Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| guanetidinmonosulfat 2 %, ögondroppar |
Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
| guanetidinmonosulfat 3 %, ögondroppar |
Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) |
| guanetidinmonosulfat 0,25 % + adrenalin 0,05 %, ögondroppar |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
| guanetidinmonosulfat 0,5 % + adrenalin 0,1 %, ögondroppar |
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
| guanetidinmonosulfat 1 % + adrenalin 0,5 %, ögondroppar |
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
| Guanfacine hydrochloride 1.0mg tablet |
Guanfacine (as guanfacine hydrochloride) 1 mg oral tablet |
| guanfacinhydrokorid 1 mg, depåtablett |
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guanfacinhydrokorid 2 mg, depåtablett |
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guanfacinhydrokorid 3 mg, depåtablett |
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guanfacinhydrokorid 4 mg, depåtablett |
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet |
| Guide wire placement via previous catheter |
Insertion - action (qualifier value) |
| Gummata of yaws |
Nodular late yaws |
| Gummatous frambeside |
Nodular late yaws |
| krut |
Gunpowder (substance) |
| Gunstock deformity |
Acquired cubitus varus |
| Güntherfilter för temporärt bruk |
Temporary vena cava filter |
| HPV - Human papillomavirus test declined |
Screening for Human papillomavirus declined (situation) |
| HPV - Human papillomavirus test declined |
Screening for Human papillomavirus declined (situation) |
| HTLV 2 nucleic acid detection |
HTLV 2 nucleic acid assay |
| HTLV 2 nucleic acid detection |
HTLV 2 nucleic acid assay |
| HTLV 2 nucleic acid detection |
HTLV 2 nucleic acid assay |
| HTLV-BLV virus |
Genus Deltaretrovirus (organism) |
| HTLV-III/LAV infection |
Human immunodeficiency virus infection |
| Habitual aborter |
Recurrent miscarriage |
| kolja, livsmedel |
Haddock (substance) |
| Haemobartonella canis |
Mycoplasma haemocanis (organism) |
| Haemobartonella felis |
Mycoplasma haemofelis (organism) |
| Haemobartonella muris |
Mycoplasma haemomuris (organism) |
| Haemobartonella species |
Genus Mycoplasma |
| Haemobartonellosis |
Mycoplasmal anemia (disorder) |
| Haemophilus actinomycetemcomitans |
Aggregatibacter actinomycetemcomitans |
| Haemophilus agni |
Histophilus somni (organism) |
| Haemophilus aphrophilus |
Aggregatibacter aphrophilus |
| Haemophilus canis |
Haemophilus haemoglobinophilus |
| vaccination mot Haemophilus influenzae |
Administration of Haemophilus influenzae type B vaccine |
| Haemophilus pleuropneumoniae |
Actinobacillus pleuropneumoniae |
| Haemophilus segnis |
Aggregatibacter segnis |
| Haemophilus somnus |
Histophilus somni (organism) |
| Haemorrhagic fever with renal syndrome |
Hemorrhagic fever with renal syndrome (disorder) |
FHIR